PHIL420

Patient Advocate since 1977


Leave a comment

Isodiol

http://www.phil420.com in collaboration with partners around the world, Isodiol supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. After growing and harvesting hemp on an industrial scale, it is then processed to extract cannabidiol (CBD) to the highest purity possible for worldwide distribution.

By fostering key relationships around the globe, Isodiol and its team of collaborators have brought together experienced chemists, professors, and technicians who have performed 15 years of in­depth study of hemp plants and CBD hemp oil. These studies have resulted in unique cultivars that Isodiol and its partners then process to extract pure CBD oil.

Isodiol and its team of collaborators own exclusive technological and production capacity rights that cannot be found anywhere else in the world. The team has worked tirelessly to bring together the most talented technological minds to breed and cultivate hemp. This team of staff has extensive experience in planting, development, research and CBD production. These experts have created a process that allows them to extract pure CBD oil from the mature stalks of the hemp plant. This proprietary extraction method is unique and ensures that Isodiol’s pure CBD products are the highest quality available anywhere in the world.

Even as the largest global industrial source of CBD hemp oil worldwide, there has been no sacrifice to the ongoing commitment to sustainable agriculture. Isodiol supports small hemp farmers who are committed to growing their non­GMO crop without using pesticides, herbicides and insecticides. And, as a naturally resilient plant, hemp does not require chemicals to thrive.

Isodiol’s team of collaborators operate facilities located in close proximity to hemp fields and skilled human resources. This proximity optimizes industrial cannabinoid oil production and increases the efficacy of operating costs. This enables CBD oil to be offered wholesale to large manufacturers and CBD oil products to individual consumers at affordable rates. The goal is to create a mutually beneficial relationship with the pharmaceutical, cosmetic and nutraceutical markets that depend on consistent supply.

Isodiol is committed to the continuing development of cannabinoid oil for the benefit of individuals worldwide. It can be used by those suffering from non­-life threatening and critical ailments, including a variety of skin conditions. To learn more about the uses of CBD oil, please visit the ‘Trials/Studies’ section of our website located at the top of the page. There, you can peruse a variety of clinical trials and medical studies detailing the effects of CBD use.
Comprised of passionate and dedicated individuals, Isodiol is committed to bringing cannabinoid oil to the global market. By working in collaboration with talented farmers, chemists, technicians, professors and businesses, Isodiol produces the highest quality CBD products available. Isodiol desires to work with pharmaceutical, nutraceutical and cosmetic companies that wish to improve the efficacy of their products by infusing them with cannabinoids. This immense operating capacity enables Isodiol to deliver on any CBD oil wholesale order, no matter the size. Contact us today to learn more about the uses of pure CBD oil and how it can benefit your health and business.

isodiol-cbd99


Leave a comment

9/11 PTSD Victims Can Finally Get Medical Marijuana in New Jersey

https://www.marijuanatimes.org/911-ptsd-victims-can-finally-get-medical-marijuana-in-new-jersey/
By Chloe Sommers on Sep 16, 2016 12:34 pm
ptsd-victims-can-finally-get-access-to-medical-marijuana-in-new-jersey

Effective immediately, New Jerseyans suffering from Post Traumatic Stress Disorder (PTSD) are allowed to be prescribed medical marijuana in lieu of anti-anxiety and anti-depressant drugs. Governor Chris Christie (R-NJ) signed the bill into law last week.

“PTSD is a debilitating medical condition affecting the ability of the men and women who have served our country to lead normal lives,” Gov. Christie wrote in a statement.

It’s a much needed remedy to help a state with so many living with the disorder from the attacks on the World Trade Center towers in neighboring New York City. “Veterans – especially post-9/11 veterans – are the group most affected by PTSD,” said Assemblyman Vincent Mazzeo. “The VA has stated that it wants each veteran to find the medication with the least amount of side effects that allows them the optimum level of independence. For many, medical marijuana is the drug that best fits that criteria and the only one to provide veterans with significant relief from the anxiety associated with PTSD.”

Introduced in January of 2016, it’s taken almost a year for the conservative, pro-war on drugs governor to add PTSD to the list of ailments that qualify for medical marijuana in New Jersey. Bill A-457/S-2345 was sponsored by Senators Nicholas Scutari and Joseph Vitale. Sen. Scutari, a Democrat and chair of the Senate Judiciary Committee, said it will keep patients from getting their medicine off of the black market. “We know that individuals with PTSD are using marijuana that they are getting from the streets and, unfortunately, they are at risk of purchasing a substance that may be laced with a dangerous additive and of getting a criminal charge,” said the Senator.

The New Jersey Compassionate Use Medical Marijuana Act was signed into law in 2010. Despite nearly six years in operation, there are less than a handful of dispensaries and fewer than 7,000 registered patients in the Garden State.

new-jersey-medical-marijuana-program-statistics
Figure 1 Annual Report for 2015 NJ MMJ Statistics, NJ.gov

PTSD is a mental health condition that is triggered by a traumatic event such as a physical or sexual assault, childhood neglect or physical abuse, a natural disaster, exposure to combat, or other extreme or life-threatening events.  Symptoms can include flashbacks, nightmares, severe anxiety, uncontrollable thoughts about the event, emotional distress, physical symptoms, feelings of numbness or detachment, engaging in dangerous or self-destructive behavior, and experiencing suicidal thoughts.


Leave a comment

Texas Hemp Industries Association Clarifies Legality Of Hemp Derived CBD Oil

 

http://www.prnewswire.com/news-releases/texas-hemp-industries-association-clarifies-legality-of-hemp-derived-cbd-oil-300328988.html

AUSTIN, Texas, Sept. 15, 2016 /PRNewswire/ — On September 7, the Texas Hemp Industries Association (TXHIA) received notice that the Texas Department of Public Safety (DPS) arrived at People’s Pharmacy’s four (4) Austin locations to confiscate various industrial hemp Cannabidiol (CBD) products.  It is the position of the TXHIA that CBD products legally produced under the Federal 2014 Farm Bill are lawful for sale.

Background:  In 2015, the Texas Legislature passed SB 339, Compassionate Use Act to allow intractable epileptics access to medical cannabis for distribution under physician oversight.  This law was reported by the media as the “low THC, high CBD bill“. Sheila Hemphill, TXHIA Policy Director surmised, “we believe the media terminology may have created confusion with various law enforcement departments by giving the false impression that CBD only comes from a medicinal cannabis plant and would be subject to DPS regulations.  We appreciate DPS’s diligence to insure product and public safety.  This investigation will bring much needed clarity to the public regarding the legality of industrial hemp CBD products containing 0.3% or less THC.  We are optimistic for a good outcome for all parties.”

About CBD:  Industrial hemp is from a variety of the Cannabis Sativa L plant with concentration levels of delta 9 Tetrahydrocannabinol (THC) of 0.3% or less as defined by the 2014 Federal Farm Bill.  Within the Cannabis Sativa L plant are molecules known as cannabinoids.  All mammals have an endocannabinoid system that is nourished from cannabinoids.  Non-cannabis plants that contain cannabinoids include:  Chocolate- Theobroma cacao, Black pepper- Piper nigrum, Coneflower –Echinacea and others.  Humans naturally produce the cannabinoids Anandamide and 2-Arachidonoylglycerol (2-AG).

Delta 9 Tetrahydrocannabinol (THC) is the only cannabinoid that creates a psychoactive effect.  In the raw plant state, the THC molecule is confined within a different non-psychoactive cannabinoid known as THCA.  Cannabidiol (CBD) is a non-psychoactive cannabinoid found in the industrial hemp plant and has been reported to have anti-inflammatory, anti-anxiety, and anti-seizure properties.

Cannabidiol derived from a legal industrial hemp plant is an essential oil, like lavender or peppermint, and is not subject to the regulation established by the Texas Compassionate Use Act.   This Act created a medical cannabis program that permits THC levels higher than the 0.3% threshold allowed for industrial hemp products. As a medical cannabis program, the Compassionate Use Act increases the THC threshold to 0.5%, and requires that CBD content be “not less than 10% by weight of cannabidiol”.  This clause is the only reference to CBD in Texas State or Federal law.

Since the DPS investigation is analyzing industrial hemp products, the TXHIA is acting as liaison between the retailers and industrial hemp vendors and DPS.  TXHIA is in close contact with DPS as they conduct their investigation into the confiscated products.  At this time, there is not a clear time frame for when DPS will conclude their investigation.  All media inquiries should be directed to the TXHIA.

“Industrial hemp products are safe, legal and can be purchased on-line or on the shelves of hundreds of retail locations in Texas.  Thousands of Texans have purchased and benefited from the use of industrial hemp products such as hemp hearts, protein, milk, cosmetics, and CBD oil,” asserts Coleman Hemphill, TXHIA Executive Director.

About: The Texas Hemp Industries Association is a 501(c) 6 state chapter of the Hemp Industries Association.

Media Contact: 

Sheila Hemphill, Policy Director, TXHIA              

325.226.3683  |  Sheila@txhia.org

Lauren Stansbury, Director of Media Relations, HIA   

402.540.1208  |  Lauren@votehemp.com


Leave a comment

Cannabis’ Skin Care Potential

https://www.leafly.com/news/health/cannabis-cbd-skin-care/?utm_medium=email&utm_campaign=B2C%20News%20-%20Week%2035%20-%20Eng&utm_source=Sailthru&utm_term=Master%20-%20Engaged%2C%20Active%2C%20Passive%2C%20or%20New 
Whether it’s acne or eczema, treating troubled skin can feel like a battleground. There are a thousand things one can try, from over the counter creams and face washes, to prescription ointments and even pills. For some, there will be success with these methods – for others, however, the quest for clear and healthy skin can be ongoing and frustrating.

Fortunately, for those who have exhausted all conventional methods, or for those who desire a plant-based natural solution, cannabis may be your skin care answer.

Cannabis’ Skin Care Potential


It’s no surprise that cannabis may possess skin-healing benefits. All the elements are there. Cannabis is a known anti-inflammatory, with antioxidant and anti-aging properties. In addition, hemp seed oil contains omega-3 and omega-6 fatty acids, which provide moisture and protection from sun damage.

The endocannabinoid system consists of many cannabinoid receptors, and a large portion of these are found in the skin. Molecules in cannabis such as THC and CBD interact with this system to create the aforementioned positive effects.

Of course, when it comes to skin care, topicals are key. Smoke, no matter the substance, is never favorable to skin. In fact, if skin care is on the forefront of one’s mind, it may be wise to forego smoking altogether in exchange forvaporizing or edibles. For targeted healing, there is a range of topical products to consider trying. Hemp oil and cannabis-derived CBD oil, for example, are gaining popularity as skin remedies.

Treating Skin Conditions with Cannabis

Treating Skin Conditions with Cannabis
Study after study shows the potential for cannabis revolutionizing the skin care world, and yet the topic remains rather obscure. Still, one need not look far to hear the stories of those who have been successful using cannabis for all types of skin ailments. One such story comes from Casey Scalf.

In 2015, Scalf developed a case of contact dermatitis on his face in reaction to tea tree oil. The rash persisted for two weeks before he sought out a dermatologist, who prescribed a steroid and anti-fungal cream. While the treatment brought relief initially, over the weeks the rash proved persistent and returned worse than ever.

Scalf returned to the dermatologist, who this time prescribed an antiseborrheic cream. It was at this point that he was also advised to halt his previous steroid and anti-fungal creams as continuation could cause scarring. Alarmed at this news, Scalf decided to research the new prescription he had been given, only to find it would not cure, only suppress his symptoms.

He concluded that it was time to do his own research, and as a result he decided to give CBD oil a try. Scalf acquired an activated, pure CBD oil, and proceeded to mix it on a 1:1 ratio with organic coconut oil. After a hot shower to open the pores, he applied the mixture gently until it began to absorb. Scalf did note that his mixture can cause burning or irritation to the eyes. Since the rash was on his face, he had to be careful to avoid his eyes.

Scalf continued this treatment for a week, making sure to diligently document the progress through . By day seven, he reports that his dermatitis was completely gone.

Nine months after his experiment, Scalf published his findings in September 2015. Now, nearly a year later, he provided an update on his skin condition.

“Since that seventh day it’s been clear skies ever since. I’ve had no remission or relapse; it hasn’t come back.” Scalf said. He marveled at the realization that it’s been over a year since the debacle ended. Unlike the prescription creams he used, which merely treated the symptoms, he said the CBD method was “pretty clear-cut.”

While Scalf thinks his recipe could be tried for other conditions, such as warts or acne, so far he hasn’t heard of anyone else giving his formula a go, so for now it remains speculation. That being said, with the abundance of studies already available on the subject, it’s not farfetched to envision all the benefits of cannabis and hemp seed oil for skin.

A Market Ripe for Cannabis Skin Care Products


Scalf’s case exemplifies the potential CBD has in curing contact dermatitis, but other examples abound. Studies have shown potential benefits of cannabinoids in the treatment of psoriasis, due to its anti-inflammatory properties. Other accounts tote success using cannabis as a treatment for everything from acne to eczema.

When one considers how prevalent skin conditions are, it becomes clear that a safe, effective treatment is not only necessary but will be largely embraced by a huge subset of the population. The American Academy of Dermatologyreports that 50 million Americans are affected by acne annually. Although the majority of sufferers are under the age of 24, approximately 15% of those afflicted are adults. Additionally, reported costs of treating acne are said to collectively exceed $3 billion.

And that’s just acne alone. Combine those statistics with the approximately7.5 million U.S. citizens who have psoriasis, 28 million who have (specifically) atopic dermatitis, and the billion dollar anti-aging market, and a very clear picture is painted. Skin care remedies are a deeply sought after and much-needed treatment.

It says a lot that the market is so over-saturated with variations of creams, pills and washes, both prescription and non-prescription alike. Some will find relief in variations of these products. For others, the search for relief seems endless. In truth, there has been no single guaranteed solution, no matter what the flashy commercials may have one believe.

However, as studies on the effects of cannabis skin care continue to emerge, and the understanding of the endocannabinoid system and its receptors improves, a new, unprecedented skin care market may well begin to develop. Although it will surely include a range of products like its predecessor, with mixed creams and balms containing all manner of oils in conjunction with cannabis, the beauty of cannabis skin care is that when all is said and done, the main ingredient, whether it be CBD, THC, or a combination thereof, will be readily available to make as luxurious or as simple of a treatment as desired.


Leave a comment

Study: Oral THC Safe And Effective For Treatment Of Spasticity In Pediatric Patients – Dusseldorf, Germany

http://norml.org/news/2016/09/01/study-oral-thc-safe-and-effective-for-treatment-of-spasticity-in-pediatric-patients 

Thursday, 01 September 2016

Study: Oral THC Safe And Effective For Treatment Of Spasticity In Pediatric PatientsDusseldorf, Germany: The administration of oral, synthetic THC (dronabinol) is safe and effective for the treatment of refractory spasticity in pediatric patients, according to clinical data published online ahead of print in the European Journal of Pediatric Neurology.

Researchers from the University of Dusseldorf in Germany assessed the palliative treatment of dronabinol in 16 adolescent subjects with complex neurological conditions. Subjects received dosing twice daily and the median duration of treatment was 181 days.

Oral THC administration was associated with reduced spasticity in the majority of subjects treated. No serious or enduring side effects were reported. “Our data show evidence that dronabinol can effectively be administered over a longer period of time to … young children … without severe side effects or aggravation of pre-existing concurrent conditions,” authors concluded.

The study is one of the first trials to specifically assess the safety and efficacy of THC in an adolescent patient population.

The US Food and Drug Administration approved the prescription use of oral, synthetic THC as an anti-emetic and as an appetite stimulant in the mid 1980s. A liquid version of dronabinol was FDA approvedfor similar purposes earlier this year.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Effective treatment of spasticity using dronabinol in pediatric palliative care,” appears in the European Journal of Pediatric Neurology.